Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Exp Brain Res. 2010 Nov 17;208(3):335–343. doi: 10.1007/s00221-010-2485-y

Table 1.

Summary of INO patients studied

Patient No. Agea Sex Durationb MS type INO Visual acuityb Medicines with CNS effects
1 62 M 23 SP B 20/20;20/20 Baclofen; donepezil
2 74 M 19 RR R 20/25;20/30 Alprazolam
3 53 F 10 SP R 20/50;20/30 Gabapentin; memantine
4 46 M 6 PP R 20/20;20/30 Gabapentin; amantidine

Duration is in years

Sex: M male, F female

MS type: SP secondary progressive, RR relapsing-remitting, PP primary progressive

a

Age is in years

b

Visual acuity is right eye; left eye, measured at near with correction